Analyzing mental health treatment data from Greenbrook
Official title: Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Run by Neuronetics · NCT06997549 · Data updated 2026-11-12
This study looks at past treatment data from Greenbrook to see how well different mental health treatments, like NeuroStar TMS and Esketamine, work for people with depression, OCD, and anxiety.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 100 Years |
| Sex | All |
| Enrollment | 12000 (estimated) |
| Sponsor | Neuronetics Academic / other |
| Locations | 1 site (Malvern, Pennsylvania) |
| Status | Recruiting |
| Started | May 15, 2025 |
| Main results expected | December 2035 |
| Study ends | December 2035 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT06997549 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals who have received treatment for mental health conditions documented in the Greenbrook database since 2011.
✕Probably not a fit
Patients with incomplete treatment information or those not documented in the database may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study conducts multiple retrospective analyses of data collected from patients treated at Greenbrook to evaluate the effectiveness and utilization of various mental health treatments. It focuses on conditions such as depression, OCD, and anxiety depression, specifically examining treatments like NeuroStar TMS and Esketamine. By analyzing existing clinical data, the study aims to provide insights into the efficacy of these treatment options for mental health conditions.
Why it matters
Potential benefit: If successful, this study could enhance understanding of effective mental health treatments, leading to improved patient care.
How similar studies have gone: Other studies analyzing retrospective data on mental health treatments have shown promise, indicating that this approach can yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date in 2011 or later. Exclusion Criteria: • Incomplete information on treatment parameters
Where it's running
-
Neuronetics
Malvern, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Neha Goyal
- Email: neha.goyal@neurostar.com
- Phone: 7635281599
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Analyzing patient data to understand TMS effects on depression and anxiety
This study looks at real patient data to see how different factors affect the success of TMS therapy for people dealing with depression and anxiety.
-
Using RxWell to Reduce Opioid Use After Knee or Hip Surgery
This study is testing whether a digital tool called RxWell can help people with mood disorders who are having knee or hip surgery reduce their opioid use and improve their mental health after the operation.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.